These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38713003)

  • 21. Efficacy of the association of topical minoxidil and topical finasteride compared to their use in monotherapy in men with androgenetic alopecia: A prospective, randomized, controlled, assessor blinded, 3-arm, pilot trial.
    Rossi A; Caro G
    J Cosmet Dermatol; 2024 Feb; 23(2):502-509. PubMed ID: 37798906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
    Penha MA; Miot HA; Kasprzak M; Müller Ramos P
    JAMA Dermatol; 2024 Jun; 160(6):600-605. PubMed ID: 38598226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between "5% minoxidil plus 2% flutamide" solution vs. "5% minoxidil" solution in the treatment of androgenetic alopecia.
    Faghihi G; Iraji F; Siadat AH; Saber M; Jelvan M; Hoseyni MS
    J Cosmet Dermatol; 2022 Oct; 21(10):4447-4453. PubMed ID: 35152531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized clinical trial comparing 5% and 1% topical minoxidil for the treatment of androgenetic alopecia in Japanese men.
    Tsuboi R; Arano O; Nishikawa T; Yamada H; Katsuoka K
    J Dermatol; 2009 Aug; 36(8):437-46. PubMed ID: 19691748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excellent response to mesotherapy as adjunctive treatment in male androgenetic alopecia.
    Melo DF; de Mattos Barreto T; Plata GT; Araujo LR; Tortelly VD
    J Cosmet Dermatol; 2020 Jan; 19(1):75-77. PubMed ID: 31066492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient-reported treatment outcomes and safety of direct-to-consumer teledermatology for finasteride treatment in male androgenetic alopecia: A cross-sectional study.
    von Büren J; Hansen I; Kött J; Schröder F; Veneroso J; Schneider SW; Abeck F
    Digit Health; 2023; 9():20552076231205740. PubMed ID: 37808234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
    Suchonwanit P; Rojhirunsakool S; Khunkhet S
    Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.
    Shanshanwal SJ; Dhurat RS
    Indian J Dermatol Venereol Leprol; 2017; 83(1):47-54. PubMed ID: 27549867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interventions for female pattern hair loss.
    van Zuuren EJ; Fedorowicz Z; Schoones J
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD007628. PubMed ID: 27225981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effectiveness of treatments for androgenetic alopecia: A systematic review and meta-analysis.
    Adil A; Godwin M
    J Am Acad Dermatol; 2017 Jul; 77(1):136-141.e5. PubMed ID: 28396101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride.
    Walsh DS; Dunn CL; James WD
    Arch Dermatol; 1995 Dec; 131(12):1373-5. PubMed ID: 7492124
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study.
    Alves R; Grimalt R
    Dermatol Surg; 2018 Jan; 44(1):126-130. PubMed ID: 28562433
    [No Abstract]   [Full Text] [Related]  

  • 34. Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
    Pindado-Ortega C; Saceda-Corralo D; Buendía-Castaño D; Fernández-González P; Moreno-Arrones ÓM; Fonda-Pascual P; Alegre-Sánchez A; Rodrigues-Barata AR; Vañó-Galván S
    Actas Dermosifiliogr (Engl Ed); 2018; 109(6):536-542. PubMed ID: 29656764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical observation of basic fibroblast growth factor (bFGF) combined with minoxidil in the treatment of male androgenetic alopecia.
    Liu C; Zhao H; Zhang Y; Wu W
    J Cosmet Dermatol; 2022 Sep; 21(9):4053-4059. PubMed ID: 35037386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
    Gupta AK; Talukder M
    J Cosmet Dermatol; 2022 May; 21(5):1841-1848. PubMed ID: 35238144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis.
    Abdi P; Awad C; Anthony MR; Farkouh C; Kenny B; Maibach HI; Ogunyemi B
    Arch Dermatol Res; 2023 Dec; 315(10):2775-2785. PubMed ID: 37665358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the efficacy and quality of Life improvements of botulinum toxin type a with topical minoxidil versus topical minoxidil in male androgenetic alopecia: a randomized controlled trial.
    Yu L; Moorthy S; Li X; Peng L; Zhang Z; Shen L; Han Y; Huang X
    Arch Dermatol Res; 2024 Aug; 316(8):532. PubMed ID: 39154106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases.
    Wu M; Yu Q; Li Q
    Oncotarget; 2016 Dec; 7(50):82074-82084. PubMed ID: 27738338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Androgenetic alopecia: drug treatment].
    Granel F
    Ann Dermatol Venereol; 2000 Jun; 127 Suppl 1():1S16-20. PubMed ID: 10962364
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.